These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 34967284

  • 1. Evaluation of Antibodies Directed Against Two GPCRs, Anti-AT1R and Anti-ETAR, on Kidney Transplant Outcome.
    El Band JEK, Llorente S, Martinez-Garcia P, Alfaro R, Jimenez-Coll V, Boix F, Galián JA, Martinez-Banaclocha H, Botella C, Moya-Quiles MR, Minguela A, Legaz I, Muro M.
    Curr Protein Pept Sci; 2021; 22(10):745-757. PubMed ID: 34967284
    [Abstract] [Full Text] [Related]

  • 2. Non-HLA antibodies: angiotensin II type 1 receptor (anti-AT1R) and endothelin-1 type A receptor (anti-ETAR) are associated with renal allograft injury and graft loss.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Zmonarski S, Mazanowska O, Krajewska M, Bartoszek D, Zabińska M, Myszka M, Kamińska M, Hałoń A, Dawiskiba T, Szyber P, Sas A, Klinger M.
    Transplant Proc; 2014 Oct; 46(8):2618-21. PubMed ID: 25380879
    [Abstract] [Full Text] [Related]

  • 3. A 3-Center Study Reveals New Insights Into the Impact of Non-HLA Antibodies on Lung Transplantation Outcome.
    Reinsmoen NL, Mirocha J, Ensor CR, Marrari M, Chaux G, Levine DJ, Zhang X, Zeevi A.
    Transplantation; 2017 Jun; 101(6):1215-1221. PubMed ID: 27973391
    [Abstract] [Full Text] [Related]

  • 4. The influence of non-HLA antibodies directed against angiotensin II type 1 receptor (AT1R) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Zmonarski S, Protasiewicz M, Nowakowska B, Hałoń A, Chudoba P, Klinger M.
    Transpl Int; 2014 Oct; 27(10):1029-38. PubMed ID: 24909812
    [Abstract] [Full Text] [Related]

  • 5. Levels of angiotensin II type-1 receptor antibodies and endothelin-1 type-A receptor antibodies correlate with antibody-mediated rejection and poor graft function in kidney-transplantation patients.
    Liu C, Kang ZY, Yin Z, Xiao Y, Liu W, Zhao Y, Li DH.
    Transpl Immunol; 2022 Oct; 74():101674. PubMed ID: 35901953
    [Abstract] [Full Text] [Related]

  • 6. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes.
    Banasik M, Boratyńska M, Kościelska-Kasprzak K, Krajewska M, Mazanowska O, Kamińska D, Bartoszek D, Zabińska M, Myszka M, Nowakowska B, Hałoń A, Dawiskiba T, Chudoba P, Klinger M.
    Transpl Immunol; 2014 Jan; 30(1):24-9. PubMed ID: 24184747
    [Abstract] [Full Text] [Related]

  • 7. Non-HLA Autoantibodies at 1 Year Negatively Affect 5-Year Native Renal Function in Liver Transplant Recipients.
    O'Leary JG, Philippe A, Freeman R, Heidecke H, Jennings LW, Catar R, Klintmalm GB, Dragun D.
    Transplant Proc; 2021 Apr; 53(3):1019-1024. PubMed ID: 33579550
    [Abstract] [Full Text] [Related]

  • 8. Non-HLA agonistic anti-angiotensin II type 1 receptor antibodies induce a distinctive phenotype of antibody-mediated rejection in kidney transplant recipients.
    Lefaucheur C, Viglietti D, Bouatou Y, Philippe A, Pievani D, Aubert O, Duong Van Huyen JP, Taupin JL, Glotz D, Legendre C, Loupy A, Halloran PF, Dragun D.
    Kidney Int; 2019 Jul; 96(1):189-201. PubMed ID: 31005275
    [Abstract] [Full Text] [Related]

  • 9. Clinical Impact of Pre-transplant Antibodies Against Angiotensin II Type I Receptor and Major Histocompatibility Complex Class I-Related Chain A in Kidney Transplant Patients.
    Min JW, Lee H, Choi BS, Park CW, Yang CW, Kim YS, Choi YJ, Oh EJ, Chung BH.
    Ann Lab Med; 2018 Sep; 38(5):450-457. PubMed ID: 29797816
    [Abstract] [Full Text] [Related]

  • 10. Deleterious effect of anti-angiotensin II type 1 receptor antibodies detected pretransplant on kidney graft outcomes is both proper and synergistic with donor-specific anti-HLA antibodies.
    Malheiro J, Tafulo S, Dias L, Martins S, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    Nephrology (Carlton); 2019 Mar; 24(3):347-356. PubMed ID: 29451342
    [Abstract] [Full Text] [Related]

  • 11. Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection.
    Lee H, Kim JI, Moon IS, Chung BH, Yang CW, Kim Y, Han K, Oh EJ.
    Ann Lab Med; 2015 May; 35(3):314-20. PubMed ID: 25932439
    [Abstract] [Full Text] [Related]

  • 12. Early Acute Microvascular Kidney Transplant Rejection in the Absence of Anti-HLA Antibodies Is Associated with Preformed IgG Antibodies against Diverse Glomerular Endothelial Cell Antigens.
    Delville M, Lamarthée B, Pagie S, See SB, Rabant M, Burger C, Gatault P, Giral M, Thaunat O, Arzouk N, Hertig A, Hazzan M, Matignon M, Mariat C, Caillard S, Kamar N, Sayegh J, Westeel PF, Garrouste C, Ladrière M, Vuiblet V, Rivalan J, Merville P, Bertrand D, Le Moine A, Duong Van Huyen JP, Cesbron A, Cagnard N, Alibeu O, Satchell SC, Legendre C, Zorn E, Taupin JL, Charreau B, Anglicheau D.
    J Am Soc Nephrol; 2019 Apr; 30(4):692-709. PubMed ID: 30850439
    [Abstract] [Full Text] [Related]

  • 13. Humoral immunity in hand transplantation: anti-HLA and non-HLA response.
    Banasik M, Jabłecki J, Boratyńska M, Kamińska D, Kościelska-Kasprzak K, Bartoszek D, Chełmoński A, Hałoń A, Baran W, Klinger M.
    Hum Immunol; 2014 Aug; 75(8):859-62. PubMed ID: 24952209
    [Abstract] [Full Text] [Related]

  • 14. Non-HLA Antibodies and Epitope Mismatches in Kidney Transplant Recipients With Histological Antibody-Mediated Rejection.
    Crespo M, Llinàs-Mallol L, Redondo-Pachón D, Butler C, Gimeno J, Pérez-Sáez MJ, Burballa C, Buxeda A, Arias-Cabrales C, Folgueiras M, Sanz-Ureña S, Valenzuela NM, Reed EF, Pascual J.
    Front Immunol; 2021 Aug; 12():703457. PubMed ID: 34305943
    [Abstract] [Full Text] [Related]

  • 15. Pre-transplant AT1R antibodies correlate with early allograft rejection.
    Gareau AJ, Wiebe C, Pochinco D, Gibson IW, Ho J, Rush DN, Nickerson PW.
    Transpl Immunol; 2018 Feb; 46():29-35. PubMed ID: 29217423
    [Abstract] [Full Text] [Related]

  • 16. Antibodies against Angiotensin II Type 1 and Endothelin A Receptors: Relevance and pathogenicity.
    Philogene MC, Johnson T, Vaught AJ, Zakaria S, Fedarko N.
    Hum Immunol; 2019 Aug; 80(8):561-567. PubMed ID: 31010696
    [Abstract] [Full Text] [Related]

  • 17. Effect of anti-angiotensin II type 1 receptor antibodies on the outcomes of kidney transplantation: a systematic review and meta-analysis.
    Kang ZY, Liu C, Liu W, Li DH.
    Nephrol Dial Transplant; 2022 May 25; 37(6):1171-1180. PubMed ID: 34865146
    [Abstract] [Full Text] [Related]

  • 18. Association of angiotensin II type 1 receptor antibodies with graft histology, function and survival in paediatric renal transplant recipients.
    Fichtner A, Süsal C, Schröder C, Höcker B, Rieger S, Waldherr R, Westhoff JH, Sander A, Dragun D, Tönshoff B.
    Nephrol Dial Transplant; 2018 Jun 01; 33(6):1065-1072. PubMed ID: 29444269
    [Abstract] [Full Text] [Related]

  • 19. Pretransplant sensitization against angiotensin II type 1 receptor is a risk factor for acute rejection and graft loss.
    Giral M, Foucher Y, Dufay A, Duong Van Huyen JP, Renaudin K, Moreau A, Philippe A, Hegner B, Dechend R, Heidecke H, Brouard S, Cesbron A, Castagnet S, Devys A, Soulillou JP, Dragun D.
    Am J Transplant; 2013 Oct 01; 13(10):2567-76. PubMed ID: 23919486
    [Abstract] [Full Text] [Related]

  • 20. Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
    Deltombe C, Gillaizeau F, Anglicheau D, Morelon E, Trébern-Launay K, Le Borgne F, Rimbert M, Guérif P, Malard-Castagnet S, Foucher Y, Giral M.
    Transpl Int; 2017 Nov 01; 30(11):1150-1160. PubMed ID: 28686316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.